- Home
- CMMB vs NVNI Comparison
CMMB vs NVNI Comparison
Compare CMMB & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMMB | NVNI |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | Israel | Brazil |
| Employees | N/A | 618 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0M | 13.8M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMMB | NVNI |
|---|---|---|
| Price | $1.65 | $0.81 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 37.7K | ★ 347.2K |
| Earning Date | 05-21-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.67 |
| Revenue Next Year | N/A | $26.67 |
| P/E Ratio | $44.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $0.28 |
| 52 Week High | $3.86 | $4.94 |
Technical Indicators
Market Signals| Indicator | CMMB | NVNI |
|---|---|---|
| Relative Strength Index (RSI) | 45.22 | 28.56 |
| Support Level | $1.48 | $0.52 |
| Resistance Level | $1.89 | $1.32 |
| Average True Range (ATR) | 0.16 | 0.12 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 2.09 | 6.23 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.